Novo Nordisk A/S (J.B.M., R.V.O., S.H.I., C.W.T., J.L., N.-M.V.), 2880 Bagsvaerd, Denmark; Department of Information Engineering (C.D.M., C.C.), Universita di Padova, 35131 Padova, Italy; The Centre of Inflammation and Metabolism and the Centre for Physical Activity Research (M.P., B.K.P.), Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, 2100 Copenhagen, Denmark; and Department of Metabolic Diseases (H.T., M.O., K.U., T.K.), Graduate School of Medicine, University of Tokyo, 113-8654 Tokyo, Japan.
J Clin Endocrinol Metab. 2014 Nov;99(11):4273-80. doi: 10.1210/jc.2014-1724. Epub 2014 Aug 13.
Ethnic differences have previously been reported for type 2 diabetes.
We aimed at assessing the potential differences between Caucasian and Japanese subjects ranging from normal glucose tolerance (NGT) to impaired glucose tolerance (IGT) and to type 2 diabetes.
This was a cross-sectional study with oral glucose tolerance tests to assess β-cell function, hepatic insulin extraction, and insulin sensitivity.
PARTICIPANTS included 120 Japanese and 150 Caucasian subjects.
Measures of β-cell function, hepatic extraction, and insulin sensitivity were assessed using C-peptide, glucose, and insulin minimal models.
Basal β-cell function (Φ(b)) was lower in Japanese compared with Caucasians (P < .01). In subjects with IGT, estimates of the dynamic (Φ(d)) and static (Φ(s)) β-cell responsiveness were significantly lower in the Japanese compared with Caucasians (P < .05). In contrast, values of insulin action showed higher sensitivity in the Japanese IGT subjects. Hepatic extraction was similar in NGT and IGT groups but higher in Japanese type 2 diabetic subjects (P < .01). Despite differences in insulin sensitivity, β-cell function, and hepatic extraction, the disposition indices were similar between the 2 ethnic groups at all glucose tolerance states. Furthermore, the overall insulin sensitivity and β-cell responsiveness for all glucose tolerance states were similar in Japanese and Caucasians after accounting for differences in body mass index.
Our study provides evidence for a similar ability of Japanese and Caucasians to compensate for increased insulin resistance.
先前已有研究报道 2 型糖尿病存在种族差异。
我们旨在评估从正常糖耐量(NGT)到糖耐量受损(IGT)再到 2 型糖尿病的白种人和日本人之间的潜在差异。
这是一项横断面研究,采用口服葡萄糖耐量试验来评估β细胞功能、肝胰岛素摄取和胰岛素敏感性。
参与者包括 120 名日本人和 150 名白种人。
采用 C 肽、葡萄糖和胰岛素最小模型评估β细胞功能、肝摄取和胰岛素敏感性的指标。
与白种人相比,日本人的基础β细胞功能(Φ(b))较低(P<.01)。在 IGT 患者中,日本人的动态(Φ(d))和静态(Φ(s))β细胞反应性估计值明显低于白种人(P<.05)。相比之下,日本人 IGT 患者的胰岛素作用值显示出更高的敏感性。NGT 和 IGT 组的肝摄取相似,但日本人 2 型糖尿病患者的肝摄取更高(P<.01)。尽管存在胰岛素敏感性、β细胞功能和肝摄取的差异,但在所有糖耐量状态下,2 个种族的处置指数相似。此外,在考虑到体重指数差异后,日本人与白种人在所有糖耐量状态下的整体胰岛素敏感性和β细胞反应性相似。
我们的研究提供了证据表明,日本人与白种人有相似的能力来代偿增加的胰岛素抵抗。